Medical Device News Magazine

VivaLink Proudly Announces the Launch of a Multi Vital Monitoring Solution for Infectious Respiratory Diseases

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

VivaLink, a leading provider of connected healthcare solutions known for its unique medical wearable sensor platform, announces today the availability of its new multi vital ambulatory monitoring solution for Infectious Respiratory Diseases. Currently deployed in Asia, Eastern Europe and the Middle East, it is now available in the Americas and Western Europe.

“VivaLink’s continuous temperature monitor wearable, which was used for the first time in the fight against COVID-19 in our hospital, really reduced cross infection risks for our doctors and nurses due to its capabilities to provide data and vitals remotely. We used more than 200 temperature monitors throughout our hospital, and it made a huge impact in the care we were able to provide,” said Ms Zhang, deputy director of the nursing department of the Shanghai Public Health Clinical Center.

Built upon VivaLink’s proprietary ambulatory medical wearable sensor platform, the solution can easily be set up and scaled in hospitals, nursing homes and remote environments. Even pop-up hospitals with little to no network and IT infrastructure can be supported with the flexible platform. Once deployed, nurses and caregivers can effectively manage the vitals of all patients from a centralized console to easily identify changes, and view trends and history.

The multi vital monitoring solution includes:

  • Vitals: temperature, heart rate, respiratory rate, Sp02 Oxygen Saturation , and ECG
  • Reusable sensors with continuous monitoring and live streaming
  • Centralized patient monitoring application console
  • On-premise data server software
  • RPM option with patient companion app and cloud hosting
  • Up to 21 days of continuous monitoring on a single charge

“Continuous monitoring of patients’ vitals is essential for early detection of symptoms of infectious diseases, especially as we navigate the changing landscape of COVID-19,” said Jiang Li, Founder and CEO of VivaLNK. “With temperature, heart rate and Sp02, it rounds out the key vitals for infectious respiratory diseases monitoring.”

The VivaLNK solution works by automatically and continuously collecting patient vitals, and wirelessly sending it to a secure on-premise server via a Bluetooth Low Energy (BLE) WiFi router. The data is then consolidated and presented to a centralized console for caregivers. In RPM or remote field hospital deployments, an optional patient app and mobile device, and a cloud hosted application are available.

This solution is currently deployed in 15 hospitals (1,500 beds) in China for on premise in-patient monitoring of COVID-19, and in Romania, Qatar, and UAE using the mobile option.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”